Slimming the Lower Face: Buccal Fat Removal vs. Masseter Botulinum Toxin

Patients asking for a slimmer lower face are usually offered one of two paths: surgical removal of the buccal fat pad, or injection of botulinum toxin into the masseter muscle. Marketing often lumps them together as "face slimming," which is misleading. They target different anatomy, produce different silhouettes, and carry very different long-term implications. Understanding the mechanism behind each is the only reliable way to predict which one, if either, will deliver the result a patient is imagining.

What each procedure actually changes. The buccal fat pad sits deep in the mid-cheek, between the buccinator muscle and the masseter, roughly level with the corner of the mouth. Removing a portion of it reduces fullness in the middle third of the face, below the cheekbone and in front of the jaw muscle. The masseter, by contrast, is the thick chewing muscle that runs from the cheekbone down to the angle of the jaw. When it is enlarged, often from clenching, grinding, or genetics, it widens the back of the lower face at the jaw angle. Botulinum toxin blocks acetylcholine release at the neuromuscular junction, reducing the muscle's activity. Over eight to twelve weeks the underused muscle atrophies, and the jaw angle narrows.

The diagnostic test clinicians use. A simple clinical maneuver separates the two problems. The patient clenches the teeth while the examiner palpates the jaw angle. If a firm, bulging mass appears under the fingers, masseter hypertrophy is contributing to the width, and toxin is the logical tool. If the fullness is soft, sits forward of the muscle, and does not change with clenching, it is more likely fat, either buccal fat or subcutaneous fat, and toxin will do nothing for it. Many patients have a mix of both, which is why a single procedure sometimes produces a result that feels incomplete.

Reversibility is the biggest practical difference. Masseter toxin wears off. Neuromuscular function returns over roughly four to six months, and the muscle rebuilds if treatment stops. That makes it a low-commitment trial: if the patient dislikes the narrower angle, the change is temporary. Buccal fat removal is permanent. The pad does not regenerate, and this matters more than most patients realize, because the midface loses volume naturally with age. A face that looks pleasantly sculpted at twenty-eight can look gaunt at forty-five if the buccal pad was aggressively removed. This is why many surgeons now remove the pad conservatively or decline the procedure in patients who are already lean, have low body fat, or have a family pattern of hollow cheeks.

Side effect profiles differ in kind, not just degree. Masseter toxin's main risks are functional and temporary: chewing fatigue with tough foods for a few weeks, occasional asymmetry of the smile if the toxin diffuses into nearby muscles such as the risorius or zygomaticus, and, with repeated high-dose treatment, visible sagging in patients whose skin depends on the muscle's bulk for support. Buccal fat removal is surgery through an incision inside the mouth. Its risks include infection, hematoma, asymmetry, and, rarely, injury to the parotid duct or buccal branches of the facial nerve, both of which travel near the fat pad. Nerve injury can affect the movement of the corner of the mouth. These complications are uncommon in experienced hands but they are not reversible the way a toxin side effect is.

Who tends to be a good candidate for which. Toxin suits patients with a wide, square jaw angle driven by muscle bulk, particularly those who also grind or clench, since the treatment can ease those symptoms at the same time. Buccal fat removal suits a narrower group: patients with genuinely excess buccal fullness, stable weight, adequate midface volume elsewhere, and realistic expectations that the change will be subtle in the mid-cheek rather than dramatic along the jaw. Patients whose "round face" comes from generalized subcutaneous fat or higher body weight are poor candidates for buccal removal, since the pad contributes only a fraction of overall cheek volume.

The myth worth retiring. The claim that either procedure creates "a chiseled jawline" on its own overstates what each can do. Jawline definition depends on bone projection at the chin and jaw angle, skin quality, submental fat, and neck posture, not just cheek volume or muscle size. Reducing one tissue can even unmask another problem, such as mild jowling that was previously camouflaged by fullness. A careful consultation should assess the whole lower face and, when appropriate, recommend no procedure at all.

The bottom line. These are complementary tools, not interchangeable ones. Toxin reshapes the back of the lower face temporarily by shrinking muscle. Buccal fat removal reshapes the mid-cheek permanently by removing deep fat. The clench test, an honest look at long-term facial aging, and conservative dosing or excision are what separate a good outcome from a regretted one.